CATX
Perspective Therapeutics Inc.
2.90$
+0.0%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2019 | 2020 | 2020 | 2021 | 2021 | 2022 | 2022 | 2023 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 58.3% | 47.1% | 47.1% | 49.1% | 49.1% | 57.2% | 57.2% | 56.3% | 77.0% | – | 158.6% | 367.8% | |
| 41.7% | 52.9% | 52.9% | 50.9% | 50.9% | 42.8% | 42.8% | 43.7% | 23.0% | 100.0% | -58.6% | -267.8% | |
| 20.2% | 11.6% | 11.6% | 14.2% | 14.2% | 23.9% | 23.9% | 33.5% | 36.6% | 1,486.1% | 2,705.1% | 9,526.6% | |
| 57.0% | 47.2% | 47.2% | 46.7% | 46.7% | 87.3% | 61.3% | 172.7% | 153.0% | 1,462.1% | 1,830.3% | 3,420.0% | |
| 113.8% | 88.8% | 88.8% | 85.1% | 85.1% | 168.5% | 111.2% | 211.8% | 245.3% | 2,955.0% | 4,535.4% | 12,846.6% | |
| -72.2% | -35.9% | -35.9% | -34.2% | -34.2% | -68.5% | -68.5% | -168.1% | -213.7% | -2,855.0% | -4,594.0% | -12,846.6% | |
| 1.8% | – | 0.3% | – | 0.5% | – | 1.1% | 2.2% | – | 5.9% | 3.3% | 42.5% | |
| -70.3% | -35.6% | -35.6% | -33.7% | -33.7% | -67.4% | -67.4% | -156.7% | -206.5% | -2,796.8% | -5,531.4% | -11,813.1% | |
| -4.0% | -1.8% | -1.8% | -2.0% | -2.0% | – | -1.1% | -2.2% | – | -184.9% | -144.2% | -89.7% | |
| -66.3% | -33.8% | -33.8% | -31.7% | -31.7% | -67.4% | -66.3% | -198.7% | -206.5% | -3,243.2% | -5,452.5% | -11,665.3% | |
| -72.5% | -35.9% | -34.4% | -34.1% | -34.1% | – | -66.2% | -156.6% | -208.9% | -2,786.6% | -4,435.4% | -11,402.8% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.